Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Boris Minev

    TitleAssociate Adjunct Professor
    SchoolUniversity of California, San Diego
    DepartmentRadiation Medicine and Applied Science
    Address9500 Gilman Drive #0820
    CA La Jolla 92093
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Kilinc MO, Ehrig K, Pessian M, Minev B, Szalay AA. Colonization of xenograft tumors by oncolytic vaccinia virus (VACV) results in enhanced tumor killing due to the involvement of myeloid cells. J Transl Med. 2016 Dec 20; 14(1):340. PMID: 27993141.
        View in: PubMed
      2. Huang T, Wang H, Chen NG, Frentzen A, Minev B, Szalay AA. Expression of anti-VEGF antibody together with anti-EGFR or anti-FAP enhances tumor regression as a result of vaccinia virotherapy. Mol Ther Oncolytics. 2015; 2:15003. PMID: 27119102.
        View in: PubMed
      3. Lyday B, Chen T, Kesari S, Minev B. Overcoming tumor immune evasion with an unique arbovirus. J Transl Med. 2015; 13(1):3. PMID: 25592450.
        View in: PubMed
      4. Saenz R, Futalan D, Leutenez L, Eekhout F, Fecteau JF, Sundelius S, Sundqvist S, Larsson M, Hayashi T, Minev B, Carson D, Esener S, Messmer B, Messmer D. TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant. J Transl Med. 2014; 12(1):211. PMID: 25123824.
        View in: PubMed
      5. Wagner SC, Markosian B, Ajili N, Dolan BR, Kim AJ, Alexandrescu DT, Dasanu CA, Minev B, Koropatnick J, Marincola FM, Riordan NH. Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy. J Transl Med. 2014; 12:127. PMID: 24884532; PMCID: PMC4028098.
      6. Wang H, Chen NG, Minev B, Zimmermann M, Aguilar RJ, Zhang Q, Sturm JB, Fend F, Yu YA, Cappello J, Lauer UM, Szalay AA. Optical detection and virotherapy of live metastatic tumor cells in body fluids with vaccinia strains. PLoS One. 2013; 8(9):e71105. PMID: 24019862; PMCID: PMC3760980.
      7. Duggal R, Minev B, Geissinger U, Wang H, Chen NG, Koka PS, Szalay AA. Biotherapeutic approaches to target cancer stem cells. J Stem Cells. 2013; 8(3-4):135-49. PMID: 24699023.
        View in: PubMed
      8. Ramdass B, Duggal R, Minev B, Chowdhary A, Koka P. Functional role of solid tumor stem cells in disease etiology and susceptibility to therapeutic interventions. J Stem Cells. 2013; 8(3-4):189-231. PMID: 24699025.
        View in: PubMed
      9. Wang H, Chen NG, Minev B, Szalay AA. Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells. J Transl Med. 2012; 10:167. PMID: 22901246; PMCID: PMC3478222.
      10. Virtuoso LP, Harden JL, Sotomayor P, Sigurdson WJ, Yoshimura F, Egilmez NK, Minev B, Kilinc MO. Characterization of iNOS(+) Neutrophil-like ring cell in tumor-bearing mice. J Transl Med. 2012; 10:152. PMID: 22846631; PMCID: PMC3478162.
      11. Ma W, Chen M, Kaushal S, McElroy M, Zhang Y, Ozkan C, Bouvet M, Kruse C, Grotjahn D, Ichim T, Minev B. PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses. Int J Nanomedicine. 2012; 7:1475-87. PMID: 22619507.
        View in: PubMed
      12. Rodriguez JP, Murphy MP, Hong S, Madrigal M, March KL, Minev B, Harman RJ, Chen CS, Timmons RB, Marleau AM, Riordan NH. Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety. Int Arch Med. 2012; 5:5. PMID: 22313603; PMCID: PMC3296619.
      13. Ma W, Smith T, Bogin V, Zhang Y, Ozkan C, Ozkan M, Hayden M, Schroter S, Carrier E, Messmer D, Kumar V, Minev B. Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy. J Transl Med. 2011; 9:34. PMID: 21450109.
        View in: PubMed
      14. Ichim TE, Minev B, Braciak T, Luna B, Hunninghake R, Mikirova NA, Jackson JA, Gonzalez MJ, Miranda-Massari JR, Alexandrescu DT, Dasanu CA, Bogin V, Ancans J, Stevens RB, Markosian B, Koropatnick J, Chen CS, Riordan NH. Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? J Transl Med. 2011; 9:25. PMID: 21375761; PMCID: PMC3061919.
      15. Ichim TE, Solano F, Lara F, Paris E, Ugalde F, Rodriguez JP, Minev B, Bogin V, Ramos F, Woods EJ, Murphy MP, Patel AN, Harman RJ, Riordan NH. Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report. Int Arch Med. 2010; 3:30. PMID: 21070647; PMCID: PMC2989319.
      16. Yang WZ, Zhang Y, Wu F, Min WP, Minev B, Zhang M, Luo XL, Ramos F, Ichim TE, Riordan NH, Hu X. Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions. J Transl Med. 2010; 8:75. PMID: 20682053; PMCID: PMC2922090.
      17. Ichim TE, Solano F, Lara F, Rodriguez JP, Cristea O, Minev B, Ramos F, Woods EJ, Murphy MP, Alexandrescu DT, Patel AN, Riordan NH. Combination stem cell therapy for heart failure. Int Arch Med. 2010; 3(1):5. PMID: 20398245; PMCID: PMC3003238.
      18. Mikirova NA, Jackson JA, Hunninghake R, Kenyon J, Chan KW, Swindlehurst CA, Minev B, Patel AN, Murphy MP, Smith L, Ramos F, Ichim TE, Riordan NH. Nutraceutical augmentation of circulating endothelial progenitor cells and hematopoietic stem cells in human subjects. J Transl Med. 2010; 8:34. PMID: 20377846; PMCID: PMC2862021.
      19. Ichim TE, Harman RJ, Min WP, Minev B, Solano F, Rodriguez JP, Alexandrescu DT, De Necochea-Campion R, Hu X, Marleau AM, Riordan NH. Autologous stromal vascular fraction cells: a tool for facilitating tolerance in rheumatic disease. Cell Immunol. 2010; 264(1):7-17. PMID: 20537320.
        View in: PubMed
      20. Clawson C, Huang CT, Futalan D, Seible DM, Saenz R, Larsson M, Ma W, Minev B, Zhang F, Ozkan M, Ozkan C, Esener S, Messmer D. Delivery of a peptide via poly(D,L-lactic-co-glycolic) acid nanoparticles enhances its dendritic cell-stimulatory capacity. Nanomedicine. 2010 Oct; 6(5):651-61. PMID: 20348031.
        View in: PubMed
      21. Zhang M, Dias P, Minev B, Koka PS. Induction characterization and targeting of human hematopoietic cancer stem cells. J Stem Cells. 2010; 5(1):1-7. PMID: 20861923.
        View in: PubMed
      22. Mikirova NA, Jackson JA, Hunninghake R, Kenyon J, Chan KW, Swindlehurst CA, Minev B, Patel AN, Murphy MP, Smith L, Alexandrescu DT, Ichim TE, Riordan NH. Circulating endothelial progenitor cells: a new approach to anti-aging medicine? J Transl Med. 2009; 7:106. PMID: 20003528; PMCID: PMC2804590.
      23. Riordan NH, Ichim TE, Min WP, Wang H, Solano F, Lara F, Alfaro M, Rodriguez JP, Harman RJ, Patel AN, Murphy MP, Lee RR, Minev B. Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med. 2009; 7:29. PMID: 19393041; PMCID: PMC2679713.
      24. Basak GW, Yasukawa S, Alfaro A, Halligan S, Srivastava AS, Min WP, Minev B, Carrier E. Human embryonic stem cells hemangioblast express HLA-antigens. J Transl Med. 2009; 7:27. PMID: 19386101; PMCID: PMC2680830.
      25. Zhong Z, Patel AN, Ichim TE, Riordan NH, Wang H, Min WP, Woods EJ, Reid M, Mansilla E, Marin GH, Drago H, Murphy MP, Minev B. Feasibility investigation of allogeneic endometrial regenerative cells. J Transl Med. 2009; 7:15. PMID: 19232091; PMCID: PMC2649897.
      26. Han X, Meng X, Yin Z, Rogers A, Zhong J, Rillema P, Jackson JA, Ichim TE, Minev B, Carrier E, Patel AN, Murphy MP, Min WP, Riordan NH. Inhibition of intracranial glioma growth by endometrial regenerative cells. Cell Cycle. 2009 Feb 15; 8(4):606-10. PMID: 19197154.
        View in: PubMed
      27. Ichim TE, Zhong Z, Kaushal S, Zheng X, Ren X, Hao X, Joyce JA, Hanley HH, Riordan NH, Koropatnick J, Bogin V, Minev B, Min WP, Tullis RH. Exosomes as a tumor immune escape mechanism: possible therapeutic implications. J Transl Med. 2008; 6:37. PMID: 18644158; PMCID: PMC2504474.
      28. Telusma G, Datta S, Mihajlov I, Ma W, Li J, Yang H, Newman W, Messmer BT, Minev B, Schmidt-Wolf IG, Tracey KJ, Chiorazzi N, Messmer D. Dendritic cell activating peptides induce distinct cytokine profiles. Int Immunol. 2006 Nov; 18(11):1563-73. PMID: 16966494.
        View in: PubMed
      29. Yi P, Yu H, Ma W, Wang Q, Minev B. Preparation of murine B7.1-glycosylphosphatidylinositol and transmembrane-anchored staphylococcal enterotoxin. A dual-anchored tumor cell vaccine and its antitumor effect. Cancer. 2005 Apr 1; 103(7):1519-28. PMID: 15739200.
        View in: PubMed
      30. Moustafa ME, Srivastava AS, Nedelcu E, Donahue J, Gueorguieva I, Shenouda SS, Minev B, Carrier E. Chimerism and tolerance post-in utero transplantation with embryonic stem cells. Transplantation. 2004 Nov 15; 78(9):1274-82. PMID: 15548963.
        View in: PubMed
      31. Minev B. Technology evaluation: HSPPC-96, antigenics. Curr Opin Mol Ther. 2003 Dec; 5(6):680-7. PMID: 14755896.
        View in: PubMed
      32. Kaminski JM, Summers JB, Ward MB, Huber MR, Minev B. Immunotherapy and prostate cancer. Cancer Treat Rev. 2003 Jun; 29(3):199-209. PMID: 12787714.
        View in: PubMed
      33. Minev B, Guo F, Gueorguieva I, Kaiser HE. Vaccines for immunotherapy of breast cancer and prostate cancer: new developments and comparative aspects. In Vivo. 2002 Nov-Dec; 16(6):405-15. PMID: 12494883.
        View in: PubMed
      34. Lombardi V, Shnaar R, Minev B, Misasi R, Gitstsi Kh, Sorice M, Troncone A. Conjugates of aberrant gangliosides in antiglioma vaccine: toxicological assay. Bull Exp Biol Med. 2002 Oct; 134(4):363-5. PMID: 12533760.
        View in: PubMed
      35. Minev B. Melanoma vaccines. Semin Oncol. 2002 Oct; 29(5):479-93. PMID: 12407513.
        View in: PubMed
      36. Mitchell MS, Kan-Mitchell J, Minev B, Edman C, Deans RJ. A novel melanoma gene (MG50) encoding the interleukin 1 receptor antagonist and six epitopes recognized by human cytolytic T lymphocytes. Cancer Res. 2000 Nov 15; 60(22):6448-56. PMID: 11103812.
        View in: PubMed
      37. Hipp JD, Hipp JA, Lyday BW, Minev B. Cancer vaccines: an update. In Vivo. 2000 Sep-Oct; 14(5):571-85. PMID: 11125541.
        View in: PubMed
      38. Minev B, Chavez FL, Dudouet BM, Mitchell MS. Synthetic insertion signal sequences enhance MHC class I presentation of a peptide from the melanoma antigen MART-1. Eur J Immunol. 2000 Aug; 30(8):2115-24. PMID: 10940901.
        View in: PubMed
      39. Minev B, Hipp J, Firat H, Schmidt JD, Langlade-Demoyen P, Zanetti M. Cytotoxic T cell immunity against telomerase reverse transcriptase in humans. Proc Natl Acad Sci U S A. 2000 Apr 25; 97(9):4796-801. PMID: 10759561.
        View in: PubMed
      40. Minev B, Chavez FL, Mitchell MS. Cancer vaccines: novel approaches and new promise. Pharmacol Ther. 1999 Feb; 81(2):121-39. PMID: 10190583.
        View in: PubMed
      41. Minev B, Chavez FL, Mitchell MS. New trends in the development of cancer vaccines. In Vivo. 1998 Nov-Dec; 12(6):629-38. PMID: 9891226.
        View in: PubMed
      42. Minev B, McFarland BJ, Spiess PJ, Rosenberg SA, Restifo NP. Insertion signal sequence fused to minimal peptides elicits specific CD8+ T-cell responses and prolongs survival of thymoma-bearing mice. Cancer Res. 1994 Aug 1; 54(15):4155-61. PMID: 7518351; NIHMSID: NIHMS38272.
        View in: PubMed
      43. Restifo NP, Minev B, Taggarse AS, McFarland BJ, Wang M, Irvine KR. Enhancing the recognition of tumour associated antigens. Folia Biol (Praha). 1994; 40(1-2):74-88. PMID: 7958066; NIHMSID: NIHMS65795.
        View in: PubMed
      Boris's Networks
      Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Similar People
      People who share similar concepts with this person.
      _
      Same Department
      Physical Neighbors
      People whose addresses are nearby this person.
      _